Vaccines Asia 2011 September 5, 2011

Date of event: 6 & 7 September 2011

Venue of event: Radisson Blu Hotel Pudong Century Park, Shanghai, China

Price: USD 2599

Early Bird Offer: Book and pay before 11 June 2011 and save up to USD 300

URL: www.vaccinesasia.com/Event.aspx?id=513792&MAC=UCY

Summary:

The importance of the time to market, lowering production cost and delivering quality vaccines has always been a critical factor to all Pharmaceutical companies. With the World Health Organization (WHO) announcing that China is complying with international standards for vaccine; it has spurred a huge opportunity for vaccine in Asia.

So what is more critical now for both Pharmaceutical companies and Biotechnology companies is to explore the various technologies, gain updates on new regulations, comprehend the quality standards and improve both upstream and downstream bioprocesses to be able to provide premium quality vaccines.

Benefits of attending:
• Emerging opportunities in Asia for Vaccine Manufacturing
• Asia’s stance in the current global clinical trials market
• Regulatory framework on vaccine production across the Asia Pacific
• Benefits and limitations of cell culture technology in manufacturing
• Special insights on the latest vaccine developments
• How to enhance your downstream efficiency through technologies
• Optimising productivity in a multiple component single-use facility

Featured Speakers:

Jessica Liu,
MD Senior Director of Clinical Operations,
Head of Asia-Pacific, Inc Research

Mariano Young
Vaccine Research Clinical Director
Pfizer

Ganesh Kumraj,
President of Operations,
Bharat Serums & Vaccines

Pratip Patel
Vice President & Head of Vaccine Manufacturing
Zydus Cadila

Official Website: http://www.vaccinesasia.com/Event.aspx?id=513792&MAC=UCY